Loading...
AB014. S3A-3. Precision medicine on the horizon for cholangiocarcinoma
Cholangiocarcinoma (CCA) is a molecularly heterogenous group of tumors, and tumor genotyping efforts have uncovered multiple actionable targets in both intrahepatic and extrahepatic tumors. IDH1 mutations, FGFR2 fusions, and BRAF V600E mutations are among the most promising targets to date in CCA-sp...
Na minha lista:
| Udgivet i: | Hepatobiliary Surg Nutr |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421165/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB014 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|